hai
Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Heart Transplant
As per available reports about 29 relevant Journals, 20 Conferences, 28 National symposiums are presently dedicated exclusively to heart transplant and about 1708 articles are being published on Heart Transplant.
A heart transplant, or a cardiac transplant , is a surgical transplant procedure performed on patients with end-stage heart failure or severe coronary artery disease. In this procedure patients own heart is either removed or, less commonly, left in place to support the donor heart. Post-operation survival periods average 15 years. The most common reason for heart transplant is the one or both ventricles have aren't functioning properly and severe heart failure is present. Ventricular failure can happen in many forms of congenital heart disease, but is more common in congenital defects with a single ventricle or if long-standing valve obstruction or leakage has led to irreversible heart failure. Patients who as children had the Fontan procedure, which helps complex congenital heart defects, may need a heart transplant because the blood flow through the venous system is slow and the veins are congested, which can lead to swelling, fluid accumulation, and protein loss.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and importance:
For some children with heart disease, even the most aggressive treatment with medication or conventional cardiac surgery is not enough to restore health and maintain a good quality of life. These children may be considered for heart transplantation. Heart transplantation is not a cure, and late complications can occur. After transplantation, a child can develop an infection or rejection at any time; however, both become less likely after the first year. Children on chronic immunosuppressive medications are also at increased risk for developing cancer, especially a particular cancer of the blood stream called lymphoma. According to the ISHLT data, the risk of lymphoma in pediatric heart transplant patients is approximately eight percent at 10 years. Congenital malformations are still the most common indication for infant heart transplantation. Congenital cardiomyopathy occurs in approximately 1 in 10,000 live births. The most common indication for heart transplantation in older children is cardiomyopathy. The number of children who have failing cardiac function late after palliative surgery for congenital heart disease is increasing. An important example is so-called failed Fontan.
An estimated 10% of congenital heart disease cases have been deemed uncorrectable. One of the most common indications for infant heart transplantation had been hypoplastic left heart syndrome (HLHS), which occurs in about 1 in 6000 live births. HLHS has diminished as an indication for heart transplantation because of the limited donor supply and the improvements that have been achieved in the surgical palliative approach (ie, the Norwood procedure, with or without the Sano modification).
Market Analysis:
Approximately 4000 heart transplantation procedures are performed annually worldwide. In the United States, approximately 3000 patients are awaiting transplantation, but only 2000 patients undergo transplantation annually because of lack of donor hearts. Long-term outcomes after transplantation have improved with the advances made in transplant candidate selection, surgical techniques, immunosuppressive modalities, and postoperative care. The current survival rate after heart transplantation has been reported as approximately 50%.In carefully selected people, a heart transplant can be very successful. About 87 out of 100 people who have a heart transplant survive for at least 1 year. About 50 out of 100 survive 10 years.
International symposium and workshops
1. The 3rd International Conference on Heart & Brain (ICHB 2016)
2. HEART 2015: International Symposium on Highly Efficient Accelerators and Reconfigurable Technologies
3. The 14th Annual International Symposium on Congenital Heart Disease
4. 15th Annual International Symposium on Congenital Heart Disease
List of Best International Conferences:
1. 6th Clinical Cardiology Conference November 30-December 02, 2015 San Antonio, USA
2. 7th Cardiothoracic Conference March 29-30, 2016 Atlanta, USA
3. 8th Cardiologists Conference July 18-20, 2016 Berlin, Germany
4. Cardiac Nursing Conference May 5-7, 2016 Chicago, USA
5. 2nd Pediatric Cardiology Conference September 22-24, 2016, Las Vegas, USA
6. Transplantation Conference March 28-29, 2016 Atlanta, USA
7. 4th Healthcare Conference July 18-20, 2016 Brisbane, Australia
8. Healthcare Conference November 09-11, 2015 Dubai, UAE
9. 8th Healthcare Conference October 13-15, 2016 Dubai, UAE
10. 6th Healthcare and Fitness Conference August 22-24, 2016 Philadelphia, USA
11. Healthcare Conference October 05-07, 2015 New Delhi, India
12. Hypertension Conference, Aug 4-6, 2016, Toronto, Canada
13. 10th Interventional Cardiology Conference, Sept 12-14, 2016, Berlin, Germany
14. Cardiovascular Imaging Conference, Nov 7-9, 2016, Istanbul, Turkey
15. Angiology Conference Dec 8-10, 2016,San Antonio, USA
16. Internal Medicine Conference, November 03-05, 2016 Baltimore, Maryland, USA
17. Anesthesia and Intensive Care conference September 12-14, 2016 Phoenix, Arizona, USA
18. 4th Surgery Conference October 05-07, 2015 Crowne Plaza, Dubai, UAE
19. 5th Surgery Conference October 06-08, 2016 Alicante, Spain
20. 2nd Pain Medicine Conference May 16-18, 2016 San Antonio, USA
21. Hospice and Palliative Care Conference August 31-September 02, 2015 Orlando, USA
22. 2nd Hospice and Palliative Care Conference August 25-27, 2016 Philadelphia, USA
23. International Conference on Basic and Clinical Multimodal Imaging 01-05 September, 2015 Utrecht, Netherlands
24. Hands-On Cardiac Ultrasound Imaging & Doppler 14-19 Sep 2015Irving (Dallas), Texas, USA
25. The 20th Annual Scientific Session of the American Society of Nuclear Cardiology 17- 20 Sep 2015 Washington, DC, USA
26. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Congress 2015 25-30 Sep 2015 Lisbon, Portugal
27. American College of Cardiology (ACC) Cardiovascular Board Review for Certification and Recertification September 8-12, 2015 Chicago, USA
28. The California Heart Rhythm Symposium September 11-12, 2015San Diego, California 92101, USA
29. New Cardiovascular Horizons (NCVH) Detroit: Multidisciplinary Strategies for Advanced Treatment of Peripheral Artery Disease and Limb Preservation September 12, 2015 Detroit, Michigan 48243, USA
30. 13th Annual Pittsburgh Vascular Symposium - Current Vascular Therapies: What Has Changed and What Is Still the Gold Standard September 10-12, 2015 Pittsburgh
31. United States Advanced Cardiac Life Support - ACLS Provider September 16-17, 2015Sioux Falls, South Dakota 57104, USA
32. Cardiac CT Practicum: The Total Experience September 28 - October 2, 2015 Baltimore, Maryland 21224, USA
Relevant Society and Associations
1. The American Association of Cardiovascular and Pulmonary Rehabilitation
2. American College of Cardiology (ACC)
3. American College of Cardiovascular Administrators
4. American Heart Association
5. American Stroke Association
6. Association of European Paediatric Cardiologists
7. Austrian Society of Cardiology
8. Belgian Society of Cardiology
9. Belgian Young Cardiologists
10. Brazilian Society of Cardiology
11. Brazilian Society of Cardiology
12. British Cardiac Society
13. British Heart Foundation
14. Chilean Society of Cardiology & Cardiovascular Surgery
15. The Chinese Society of Cardiac Pacing and Electrophysiology
16. Colombian Society of Cardiology
17. Computers in Cardiology
18. Congenital Heart Disease
19. Czech Society of Cardiology
20. Association of Black Cardiologists
21. Association of Emergency Physicians
Companies
1. HeartWare
2. Custodiol® HTK Solution
3. ICON Interventional Systems
4. CryoLife, Inc.
5. Fisher & Paykel Healthcare Corporation Limited
6. SurModics, Inc.
7. Texas Instruments Incorporated
8. Thoratec Corporation
9. Alere Inc.
10. ConMed Corporation
11. Roche Diagnostics International Ltd.
12. Facet Technologies
13. AngioDynamics
14. WuXi Apptec
15. Stryker
16. Best Vascular Novoste
17. 3M Cardiovascular Devices, Inc.
18. F. Hoffmann-La Roche Ltd.
19. Cintas Corporation
20. Thermo Fisher Scientific Inc.
This page will be updated regularly.
This page was last updated on November 5, 2024